Matteo Benelli

Azienda Usl Toscana Centro — Italy

Medicine · Health Sciences

38h-index8.9kcitations293works1.22yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Breast Cancer Therapies(71), Cancer Genomics and Diagnostics(63), Genetic factors in colorectal cancer(39), BRCA gene mutations in cancer(29), Lung Cancer Research Studies(26)

Publications292 total

Lactate-induced H3K4me3 histone mark promotes PLOD1-driven prostate cancer invasion

2026Open Access

A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing

Genome Medicine·2026Open Access

Activity of chemotherapy in mesenchymal chondrosarcoma: a multicentre retrospective analysis within the Italian Sarcoma Group network

ESMO Open·2026Open Access

Role of ctDNA in predicting the outcome of patients with hormone receptor–positive, HER2-negative advanced breast cancer treated with first-line ribociclib and letrozole: BioItaLEE trial

Clinical Cancer Research·2026Open Access

CtDNA Detection with Low-Pass Whole-Genome Bisulfite Sequencing in RAS Wild-Type Metastatic Colorectal Cancer: An Exploratory Objective of the VALENTINO Trial

1 cited

Clinical Cancer Research·2025· 1 cited

Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01)

Clinical Cancer Research·2025

Genome-wide DNA methylation data of plasma cell-free DNA from the MIMESIS-1 and MIMESIS-2 cohorts (METER study)

1 cited

Zenodo (CERN European Organization for Nuclear Research)·2025· 1 citedOpen Access

291P Spatial transcriptomics of extrahepatic cholangiocarcinoma unravels immunosuppressive features of cancer-associated fibroblasts

Annals of Oncology·2025

Supplementary Methods from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Supplementary Table S3 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Figure S8 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Supplementary Table S1 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Figure S7 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Figure S3 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Figure S1 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Supplementary Table S2 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Figure S6 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Figure S2 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Figure S4 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

Figure S5 from BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

2025Open Access

page 1 of 15Next →

Frequent Co-authors

Francesca Demichelis(15), Luca Malorni(14), Ilenia Migliaccio(12), Angelo Di Leo(11), Dario Romagnoli(11), Himisha Beltran(9), Alberto Magi(9), Martina Bonechi(9), Mark A. Rubin(8), Francesca Torricelli(8), Chiara Biagioni(8), Davide Prandi(7), Andrea Sboner(7), Amelia McCartney(7), Joanna Cyrta(6), Olivier Elemento(6), Laura Biganzoli(6), Francesca De Luca(5), Francesca Galardi(5), Emanuela Risi(5)